Peripapillary and Macular Vascular Changes of Unilateral Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomography Angiography Study
NCT ID: NCT06031350
Last Updated: 2023-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2021-06-01
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optical Coherence Tomography Angiography in Myopic Patients
NCT04135209
Retinal Vascular Changes in Primary Open Angle Glaucoma Patients
NCT05351307
Changes of Macular Vasculature After Uncomplicated Phacoemulsification Surgery Using Optical Coherence Tomography Angiography
NCT04594603
Evaluation of Retinal Vascular Density in High Myopia Without Pathological Myopic Maculopathy Using OCTA .
NCT06596408
Ocular Changes in Vitiligo Patients on Therapy
NCT05335746
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diseased eyes
The 30 diseased eyes of the patients were considered the case group.
Optical Coherence Tomography Angiography
Optovue, Inc., Fremont, CA, USA
Fellow eyes
The 30 fellow eyes of the patients were considered the control group.
Optical Coherence Tomography Angiography
Optovue, Inc., Fremont, CA, USA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical Coherence Tomography Angiography
Optovue, Inc., Fremont, CA, USA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A normal fellow eye.
* Age ≥ 40 years old.
Exclusion Criteria
* NAION patients in chronic phase.
* Acute phase NAION patients with any other optic neuropathy in the other eye.
* Eyes with opaque media.
* Elevated intraocular pressure (\>22 mmHg).
* Refractive errors greater than 6 diopters of spherical equivalent.
* Poor cooperation with fixation or the OCTA examination.
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Omar Said
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omar Said
Assistant professor of Ophthalmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Omar Said, MD
Role: STUDY_DIRECTOR
Assistant professor of Ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Fayoum University
Al Fayyum, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EOM64
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.